- Home
- NYT vs ELAN Comparison
NYT vs ELAN Comparison
Compare NYT & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NYT | ELAN |
|---|---|---|
| Founded | 1851 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Newspapers/Magazines | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2B | 12.7B |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NYT | ELAN |
|---|---|---|
| Price | $76.28 | $23.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $72.14 | $27.89 |
| AVG Volume (30 Days) | 1.5M | ★ 6.7M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.16% | N/A |
| EPS Growth | ★ 18.08 | N/A |
| EPS | ★ 0.54 | 0.11 |
| Revenue | $1,783,639,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | $10.58 | $8.21 |
| Revenue Next Year | $6.98 | $5.31 |
| P/E Ratio | ★ $139.25 | $224.41 |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $51.03 | $13.16 |
| 52 Week High | $87.10 | $27.72 |
Technical Indicators
Market Signals| Indicator | NYT | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 48.74 | 54.23 |
| Support Level | $72.97 | $22.04 |
| Resistance Level | $82.49 | $24.06 |
| Average True Range (ATR) | 1.83 | 1.09 |
| MACD | 0.24 | 0.30 |
| Stochastic Oscillator | 77.08 | 61.64 |
Price Performance
Historical ComparisonAbout NYT New York Times Company (The)
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company derives revenue from subscriptions, advertising, and other sources, where the majority of its revenue is generated through subscriptions, which consist of income from standalone and multiproduct bundle subscriptions to its digital products and subscriptions to and single-copy and bulk sales of print products.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.